DK0869957T3 - 3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelser - Google Patents

3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelser

Info

Publication number: DK0869957T3
Authority: DK; Denmark
Prior art keywords: compounds; pharmaceutical compositions; compositions containing; pyridazinone; pyridazinone derivatives
Prior art date: 1995-05-29

Application number

DK96919967T

Other languages

English (en)

Inventor

Peter Matyus

Mariann Karim

Judit Kosary

Agnes Papp

Antal Simay

Yemane Tilahun

Eva Tomori

Edit Horvath

Katalin Horvath

Erzsebet Zara

Margit Bidlo

Alice Druga

Gyoergy Rabloczky

Marta Varga

Egon Karpati

Endre Kasztreiner

Istvan Kiraly

Gyoergy Mathe

Nandor Makk

Laszlo Harsing

Ildiko Varga

Ildiko Mathe

Laszlo Sebestyen

Original Assignee

Gyogyszerkutato Intezet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-29

Filing date

1996-05-28

Publication date

2002-07-01

1996-05-28 Application filed by Gyogyszerkutato Intezet filed Critical Gyogyszerkutato Intezet

2002-07-01 Application granted granted Critical

2002-07-01 Publication of DK0869957T3 publication Critical patent/DK0869957T3/da

Links

150000001875 compounds Chemical class 0.000 title abstract 4
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title 1
FJNRJBQUOQLUNQ-CYBMUJFWSA-N 2-[3-[[(3r)-2,3-dihydro-1,4-benzodioxin-3-yl]methylamino]propyl]pyridazin-3-one Chemical compound O=C1C=CC=NN1CCCNC[C@H]1OC2=CC=CC=C2OC1 FJNRJBQUOQLUNQ-CYBMUJFWSA-N 0.000 abstract 1
206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 abstract 1
108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 abstract 1
102000015009 alpha1-adrenergic receptor activity proteins Human genes 0.000 abstract 1
102000015006 alpha2-adrenergic receptor activity proteins Human genes 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000007858 starting material Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK96919967T 1995-05-29 1996-05-28 3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelser DK0869957T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU9501560A HU224067B1 (hu)	1995-05-29	1995-05-29	3(2H)-Piridazinon-származékok és e vegyületeket tartalmazó gyógyszerkészítmények
PCT/HU1996/000030 WO1996038441A1 (en)	1995-05-29	1996-05-28	3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds

Publications (1)

Publication Number	Publication Date
DK0869957T3 true DK0869957T3 (da)	2002-07-01

Family

ID=10986884

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96919967T DK0869957T3 (da)	1995-05-29	1996-05-28	3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelser

Country Status (13)

Country	Link
US (2)	US6194411B1 (da)
EP (1)	EP0869957B1 (da)
JP (2)	JP3857313B2 (da)
KR (1)	KR100408364B1 (da)
AT (1)	ATE214389T1 (da)
AU (1)	AU710265B2 (da)
CA (1)	CA2222724C (da)
DE (1)	DE69619861T2 (da)
DK (1)	DK0869957T3 (da)
ES (1)	ES2175100T3 (da)
HU (1)	HU224067B1 (da)
PT (1)	PT869957E (da)
WO (1)	WO1996038441A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU227237B1 (en)	2001-09-27	2010-12-28	Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag	Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
CN101120002A (zh)	2005-02-17	2008-02-06	惠氏公司	环烷基稠合的吲哚、苯并噻吩、苯并呋喃和茚衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU195645B (en) *	1985-10-30	1988-06-28	Gyogyszerkutato Intezet	Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same

1995
- 1995-05-29 HU HU9501560A patent/HU224067B1/hu not_active IP Right Cessation
1996
- 1996-05-28 US US08/973,584 patent/US6194411B1/en not_active Expired - Fee Related
- 1996-05-28 CA CA002222724A patent/CA2222724C/en not_active Expired - Fee Related
- 1996-05-28 AU AU58427/96A patent/AU710265B2/en not_active Ceased
- 1996-05-28 AT AT96919967T patent/ATE214389T1/de not_active IP Right Cessation
- 1996-05-28 DE DE69619861T patent/DE69619861T2/de not_active Expired - Fee Related
- 1996-05-28 ES ES96919967T patent/ES2175100T3/es not_active Expired - Lifetime
- 1996-05-28 PT PT96919967T patent/PT869957E/pt unknown
- 1996-05-28 WO PCT/HU1996/000030 patent/WO1996038441A1/en not_active Ceased
- 1996-05-28 EP EP96919967A patent/EP0869957B1/en not_active Expired - Lifetime
- 1996-05-28 JP JP53631996A patent/JP3857313B2/ja not_active Expired - Fee Related
- 1996-05-28 DK DK96919967T patent/DK0869957T3/da active
- 1996-05-28 KR KR1019970708521A patent/KR100408364B1/ko not_active Expired - Fee Related
2000
- 2000-08-28 US US09/649,077 patent/US6248907B1/en not_active Expired - Fee Related
2006
- 2006-06-01 JP JP2006153349A patent/JP2006316064A/ja active Pending

Also Published As

Publication number	Publication date
EP0869957A2 (en)	1998-10-14
HUT75104A (en)	1997-04-28
HU224067B1 (hu)	2005-05-30
JP3857313B2 (ja)	2006-12-13
WO1996038441A1 (en)	1996-12-05
KR100408364B1 (ko)	2004-06-14
EP0869957B1 (en)	2002-03-13
PT869957E (pt)	2002-09-30
US6194411B1 (en)	2001-02-27
ATE214389T1 (de)	2002-03-15
JPH11506094A (ja)	1999-06-02
US6248907B1 (en)	2001-06-19
AU710265B2 (en)	1999-09-16
CA2222724A1 (en)	1996-12-05
CA2222724C (en)	2006-05-23
DE69619861D1 (de)	2002-04-18
HU9501560D0 (en)	1995-07-28
JP2006316064A (ja)	2006-11-24
DE69619861T2 (de)	2002-09-26
KR19990022042A (ko)	1999-03-25
AU5842796A (en)	1996-12-18
ES2175100T3 (es)	2002-11-16

Similar Documents

Publication	Publication Date	Title
BG103964A (en)	2000-08-31	SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
TR200103273T2 (tr)	2002-04-22	Hemisentetik yöntem ve yeni bileşimler.
AP2001002172A0 (en)	2001-06-30	Substituted pyrazoles as p38 kinase inhibitors
DE69719350D1 (de)	2003-04-03	2-pyrimidinamin derivaten und verfahrens zu deren herstellung
DK0870768T3 (da)	2002-07-01	Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler
ES2132415T3 (es)	1999-08-16	Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
BR9916396A (pt)	2001-09-11	Herbicidas
FI970147A0 (fi)	1997-01-14	Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
MXPA02011370A (es)	2003-06-06	Iminoazinas substituidas.
DK0567271T3 (da)	1998-02-16	Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf
AP2001002191A0 (en)	2001-06-01	3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
TR200201683T2 (tr)	2002-12-23	İkameli fenil-piperazin türevleri, bunların hazırlanması ve kullanımları
AP2003002810A0 (en)	2003-06-30	1,4-Disubstituted piperazine derivatives useful as uro-selective a, - adrenoceptor blockers
CA2356985A1 (en)	2000-07-06	5ht1 antagonists for antidepressant therapy
AU681021B2 (en)	1997-08-14	Indole derivative and medicine containing the same
HU9501560D0 (en)	1995-07-28	3(2h)-pyridazinone derivatives and pharmaceutical compositions containing them
WO2003035651A3 (fr)	2003-11-27	Derives de l'artemisinine, et leurs utilisations dans le traitement du paludisme
MXPA04002838A (es)	2004-07-05	Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
BG106152A (en)	2002-06-28	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
DE69906243D1 (de)	2003-04-30	2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
DE69533214D1 (de)	2004-08-05	2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
MEP12408A (en)	2010-06-10	Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors
MY133098A (en)	2007-10-31	New nitromethyl ketones, process for preparing them and compositions containing them
TR199801683A2 (xx)	1999-03-22	Yeni �re t�revleri.
DE69827706D1 (de)	2004-12-30	5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems